Arvinas (ARVN) Non Operating Income (2017 - 2026)
Arvinas (ARVN) recorded quarterly Non Operating Income of $6.3 million in Q1 2026, down 83.59% quarter-over-quarter from $38.4 million in Q4 2025, and down 46.15% on a YoY basis from $11.7 million in Q1 2025.
Arvinas (ARVN) Non Operating Income (2017 - 2026) Analysis & Trends
Arvinas' Non Operating Income history runs 10 years deep, the most recent figure standing at $6.3 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 46.15% year-over-year to $6.3 million; the TTM figure through Mar 2026 stood at $53.4 million (up 373.85% YoY), while the FY2025 annual figure was $38.0 million, up 1410.34% from the prior year.
- Non Operating Income was $6.3 million for Q1 2026 at Arvinas, down from $38.4 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $38.4 million in Q4 2025 to a low of -$42.1 million in Q4 2024.
- Historically, Non Operating Income has averaged $2.6 million across 5 years, with a median of $4.0 million in 2022.
- Biggest YoY gain for Non Operating Income was 5100.0% in 2023; the steepest drop was 4550.0% in 2023.
- A 5-year view of Non Operating Income shows it stood at $600000.0 in 2022, then slumped by 4550.0% to -$26.7 million in 2023, then tumbled by 57.68% to -$42.1 million in 2024, then jumped by 191.21% to $38.4 million in 2025, then sank by 83.59% to $6.3 million in 2026.
- The last three Non Operating Income figures came in at $6.3 million (Q1 2026), $38.4 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | 6.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.30 Mn |
| Dec 31, 2025 | 38.40 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | -300,000.00 |
| Mar 31, 2025 | 11.70 Mn |
| Dec 31, 2024 | -42.10 Mn |
| Sep 30, 2024 | -2.60 Mn |
| Jun 30, 2024 | 13.50 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | -26.70 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 600,000.00 |
| Sep 30, 2022 | -200,000.00 |
| Jun 30, 2022 | 1.70 Mn |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 800,000.00 |
| Sep 30, 2021 | 500,000.00 |
| Jun 30, 2021 | 1.60 Mn |
| Mar 31, 2021 | 200,000.00 |